Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tis...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2020-08-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2426 |
_version_ | 1797700528099033088 |
---|---|
author | Tamara P. Makarova Khakim M. Vakhitov Dina R. Sabirova Dinara I. Sadykova Liliya R. Khusnutdinova Natalya N. Firsova Anna A. Kucheryavaya |
author_facet | Tamara P. Makarova Khakim M. Vakhitov Dina R. Sabirova Dinara I. Sadykova Liliya R. Khusnutdinova Natalya N. Firsova Anna A. Kucheryavaya |
author_sort | Tamara P. Makarova |
collection | DOAJ |
description | Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tissue disease may evolve into other systemic diseases over time. Description of any cases of mixed connective tissue disease and its evolution in Russian patients has not been published previously.Clinical Case Description. The results of observations of the child with clinical and immunological signs of the mixed connective tissue disease followed by the progression of systemic scleroderma symptoms and development of Sjogren's syndrome in the short period of time are presented in the article. Improvement (such as pain attenuation, increase in volume of movements in affected joints, decrease of Raynaud syndrome manifestations duration) was observed on treatment (methotrexate 10 mg/week with subsequent addition of prednisolone 0.75 mg/kg/day).Conclusion. Timely diagnostics of clinical signs of the systemic diseases debut is crucial for correct patient routing and for achieving of disease improvement. |
first_indexed | 2024-03-12T04:23:12Z |
format | Article |
id | doaj.art-a8f6e174a7854cf7ac76a8ff7778d1a7 |
institution | Directory Open Access Journal |
issn | 1682-5527 1682-5535 |
language | English |
last_indexed | 2024-03-12T04:23:12Z |
publishDate | 2020-08-01 |
publisher | "Paediatrician" Publishers LLC |
record_format | Article |
series | Вопросы современной педиатрии |
spelling | doaj.art-a8f6e174a7854cf7ac76a8ff7778d1a72023-09-03T10:32:30Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352020-08-0119321421910.15690/vsp.v19i3.21171885Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical CaseTamara P. Makarova0Khakim M. Vakhitov1Dina R. Sabirova2Dinara I. Sadykova3Liliya R. Khusnutdinova4Natalya N. Firsova5Anna A. Kucheryavaya6Казанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетДетская республиканская клиническая больницаДетская республиканская клиническая больницаBackground. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tissue disease may evolve into other systemic diseases over time. Description of any cases of mixed connective tissue disease and its evolution in Russian patients has not been published previously.Clinical Case Description. The results of observations of the child with clinical and immunological signs of the mixed connective tissue disease followed by the progression of systemic scleroderma symptoms and development of Sjogren's syndrome in the short period of time are presented in the article. Improvement (such as pain attenuation, increase in volume of movements in affected joints, decrease of Raynaud syndrome manifestations duration) was observed on treatment (methotrexate 10 mg/week with subsequent addition of prednisolone 0.75 mg/kg/day).Conclusion. Timely diagnostics of clinical signs of the systemic diseases debut is crucial for correct patient routing and for achieving of disease improvement.https://vsp.spr-journal.ru/jour/article/view/2426детисмешанное заболевание соединительной тканисиндром шарпаперекрестный синдромсиндром рейноартрит |
spellingShingle | Tamara P. Makarova Khakim M. Vakhitov Dina R. Sabirova Dinara I. Sadykova Liliya R. Khusnutdinova Natalya N. Firsova Anna A. Kucheryavaya Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case Вопросы современной педиатрии дети смешанное заболевание соединительной ткани синдром шарпа перекрестный синдром синдром рейно артрит |
title | Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case |
title_full | Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case |
title_fullStr | Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case |
title_full_unstemmed | Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case |
title_short | Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case |
title_sort | evolution of mixed connective tissue disease in 7 years old child clinical case |
topic | дети смешанное заболевание соединительной ткани синдром шарпа перекрестный синдром синдром рейно артрит |
url | https://vsp.spr-journal.ru/jour/article/view/2426 |
work_keys_str_mv | AT tamarapmakarova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT khakimmvakhitov evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT dinarsabirova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT dinaraisadykova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT liliyarkhusnutdinova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT natalyanfirsova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase AT annaakucheryavaya evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase |